Related Experiment Videos
Cefoperazone for urethritis due to penicillinase-producing Neisseria gonorrhoeae
Abstract:
Thirty-two men infected with penicillinase-producing Neisseria gonorrhoeae were treated with a single intramuscular dose of 0.5 gm of cefoperazone. Of the 29 patients who were followed up, only two (7%) failed to recover; seven patients (26%) had postgonococcal urethritis. The MICs of cefoperazone were 0.03 microgram/ml (three strains), 0.06 microgram/ml (11), 0.12 microgram/ml (nine), 0.25 microgram/ml (one), and 0.5 microgram/ml (one).
Insights
Cefoperazone effectively treated most men with penicillinase-producing Neisseria gonorrhoeae infections. However, a notable percentage experienced treatment failure or developed postgonococcal urethritis, indicating potential challenges with this antibiotic regimen.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Penicillinase-producing Neisseria gonorrhoeae (PPNG) poses a significant challenge in gonorrhea treatment.
- Antimicrobial resistance in Neisseria gonorrhoeae necessitates the evaluation of alternative therapeutic agents.
Purpose of the Study:
- To assess the efficacy and clinical outcomes of cefoperazone in treating men with PPNG infections.
- To determine the cure rates and incidence of postgonococcal urethritis following cefoperazone administration.
Main Methods:
- A clinical study involving 32 men diagnosed with PPNG infection.
- Treatment administered as a single intramuscular dose of 0.5 gm of cefoperazone.
- Follow-up assessments conducted on 29 patients to evaluate treatment outcomes and complications.
Main Results:
- A high cure rate of 93% was observed among the 29 followed-up patients.
- Seven patients (26%) developed postgonococcal urethritis post-treatment.
- Minimum Inhibitory Concentrations (MICs) of cefoperazone ranged from 0.03 to 0.5 microgram/ml across different strains.
Conclusions:
- Cefoperazone demonstrates significant efficacy in treating most cases of PPNG infections.
- The occurrence of postgonococcal urethritis warrants further investigation and consideration in treatment protocols.
- Cefoperazone represents a viable therapeutic option for PPNG, though monitoring for adverse outcomes is crucial.